Astex scientists describe novel HSP90 inhibitors in two key publications in Journal of Medicinal Chemistry

Astex scientists describe novel HSP90 inhibitors in two key publications in Journal of Medicinal Chemistry

Encouraging Interim Data From A Phase I Study Of Astex’s HSP90 Inhibitor AT13387 To Be Presented At ASCO

Encouraging Interim Data From A Phase I Study Of Astex’s HSP90 Inhibitor AT13387 To Be Presented At ASCO

Encouraging data from three Astex collaborative programmes to be presented at the 101st American Association for Cancer Research (AACR) Annual Meeting 2010

Encouraging data from three Astex collaborative programmes to be presented at the 101st American Association for Cancer Research (AACR) Annual Meeting 2010

Astex Executive Receives the AstraZeneca Business Development Professional of the Year 2009 Award

Astex Executive Receives the AstraZeneca Business Development Professional of the Year 2009 Award